Model
Edge
Regulus Therapeutics Inc
RGLS
Filing Type
8-K
Filing Date
6/24/2025
Updated
6/25/25, 3:12 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-2.2
EXHIBIT 2.2
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2